Default: Europace

ISSN: 1099-5129

Journal Home

Journal Guideline

Europace Q1 Unclaimed

Oxford University Press United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Europace is a journal indexed in SJR in Physiology (medical) and Cardiology and Cardiovascular Medicine with an H index of 128. It has an SJR impact factor of 2,895 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,895.

Europace focuses its scope in these topics and keywords: atrial, fibrillation, pulmonary, cardiac, study, multicentre, isolation, contact, ablation, clinical, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -


- €

Inmediate OA


Embargoed OA

0 €

Non OA




SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)




No comments ... Be the first to comment!

Aims and Scope

atrial, fibrillation, pulmonary, cardiac, study, multicentre, isolation, contact, ablation, clinical, effect, force, heart, pilot, single, ventricular, veins, vein, electronic, fluoroscopy, left, pacing, patients, procedure, tachycardia,

Best articles by citations

Impaired arterial baroreceptor sensitivity before tilt-induced syncope

View more

Ice mapping during cryothermal ablation of accessory pathways in WPW: the role of the temperature time constant

View more

Detection by intracardiac echocardiography of early formation of left atrial thrombus during pulmonary vein isolation

View more

Clinical value of routine predischarge testing after ICD-implantation

View more

Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference

View more

Differences of two cryoballoon generations: insights from the prospective multicentre, multinational FREEZE Cohort Substudy

View more

Development and validation of a risk score for predicting atrial fibrillation recurrence after a first catheter ablation procedure -ATLAS score

View more

A01-1 Adenosine-induced syncope: Prevalence and characteristics

View more

A01-2 Detecting baroreflex activity by a sequential analysis during head-up tilt test in young women with syncope

View more

42Atrial fibrillation ablation as a day-case procedure: three-year single-centre experience

View more

A01-3 The effect of beta-blockers on the central serotonergic responsivity, in patients with neurocardiogenic syncope

View more

A01-4 Response to head-up tilt testing and follow-up in patients with situational syncope; Comparison with vasovagal syncope

View more

A01-5 Long-term follow-up in patients with vasovagal syncope

View more

A01-6 The application of a programme of home-based tilt ? trainig in patients suffering from vasovagal syncope

View more

A02-1 Incidence of cerebral embolism in high risk patients with atrial fibrillation

View more

A02-2 Atrial fibrillation and thrombus formation: Time depended or genetic disorders?

View more

A02-3 Conversion of atrial fibrillationto sinus rhythm could induce hyperclotting state: The relationship with the atrial fibrillation duration

View more

A02-4 Incidence of cerebral embolism in patients with atrial fibrillation and cardioversion

View more

A02-5 Endothelial damage and activation of the hemostatic system during radiofrequency catheter isolation of pulmonary veins

View more

A02-6 New automatic diagnostic functions for quantification of atrial arrhythmias in pacemaker patients

View more

A03-1 Long-term clinical outcome and device performance of biventricular pacing: A single center evaluation from three-year follow-up of consecutive heart failure patients

View more

A03-2 Cost-effectiveness analysis of biventricular pacing

View more

A03-3 Prediction of clinical response to cardiac resynchronization therapy by QRS duration and shortening

View more

A03-5 Cardiac resynchronisation therapy allows medical therapy optimization in patients with advanced congestive heart failure? Results of the insync/insyncicd Italian registries

View more